Its all there. Just need to do DD.start w/ Citius Pharmaceuticals Issues Shareholder Letter
Source: PR Newswire (US)
CRANFORD, N.J., Oct. 11, 2017
Phase 2a completed. Phase 3 ongoing. Different drugs.
Phase 3 catalysts Dec.2017
roughly trading at half cash on hand a/o today which is extremely undervalued for any company especialy for a biotech company. I believe many have not noticed her yet.just uplisted to Nasdaq.